DIAMPA LT TABLET 10/5

Diampa LT Tablet 10/5 contains a combination of two active ingredients: empagliflozin and linagliptin. Empagliflozin belongs to the class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors, while linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. This combination medication is used for the management of type 2 diabetes mellitus.

Uses:

1. Type 2 Diabetes Mellitus: Diampa LT Tablet 10/5 is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower blood sugar levels through different mechanisms: empagliflozin reduces glucose reabsorption in the kidneys, leading to increased glucose excretion in urine, while linagliptin enhances the secretion of insulin and helps reduce glucagon levels.

Side Effects:

1. Genital Infections: The use of empagliflozin may increase the risk of genital infections, such as yeast infections in females and balanitis in males. Symptoms may include itching, redness, discharge, or pain in the genital area. Good hygiene practices and prompt medical attention are recommended if such infections occur.
2. Urinary Tract Infections: Some individuals may experience urinary tract infections while taking Diampa LT Tablet 10/5. Symptoms may include frequent urination, pain or burning during urination, and cloudy or bloody urine. Drinking plenty of fluids and seeking medical attention if symptoms persist is important.
3. Hypoglycemia: When used in combination with other antidiabetic medications like insulin or sulfonylureas, Diampa LT Tablet 10/5 may increase the risk of hypoglycemia (low blood sugar). Close monitoring of blood sugar levels is essential, especially during dose adjustments or when combining with other medications.
4. Gastrointestinal Upset: Common side effects include gastrointestinal symptoms such as nausea, diarrhea, abdominal pain, and indigestion. These side effects are usually mild and transient.

When Not to Use:

1. Hypersensitivity: Individuals with a known hypersensitivity or allergy to empagliflozin, linagliptin, or any components of Diampa LT Tablet 10/5 should not use this medication.
2. Type 1 Diabetes: Diampa LT Tablet 10/5 is not indicated for the treatment of type 1 diabetes mellitus.
3. Diabetic Ketoacidosis: This combination medication should not be used in individuals with diabetic ketoacidosis, a potentially life-threatening condition characterized by high blood sugar and ketone production.
4. Severe Renal Impairment or End-Stage Renal Disease: Diampa LT Tablet 10/5 is contraindicated in individuals with severe renal impairment or end-stage renal disease, as it may further deteriorate kidney function.

Note: This is a general overview of Diampa LT Tablet 10/5 (empagliflozin & linagliptin), and it is important to consult a healthcare professional for specific information regarding your condition and individual circumstances.